MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma

por Magkouta, Sophia F., Vaitsi, Photene C., Iliopoulou, Marianthi P., Pappas, Apostolos G., Kosti, Chrysavgi N., Psarra, Katherina, Kalomenidis, Ioannis T.
Publicado 2023

CSF1/CSF1R signaling mediates malignant pleural effusion formation

por Kosti, Chrysavgi N., Vaitsi, Photene C., Pappas, Apostolos G., Iliopoulou, Marianthi P., Psarra, Katherina K., Magkouta, Sophia F., Kalomenidis, Ioannis T.
Publicado 2022

Moderate COVID-19: Clinical Trajectories and Predictors of Progression and Outcomes

por Pappas, Apostolos G., Panagopoulos, Andreas, Rodopoulou, Artemis, Alexandrou, Michaella, Chaliasou, Anna-Louiza, Skianis, Konstantinos, Kranidioti, Eleftheria, Chaini, Eleftheria, Papanikolaou, Ilias, Kalomenidis, Ioannis
Publicado 2022

Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report

por Karaolidou, Frini, Loutsidi, Natasa‐Eleni, Mellios, Zois, Jahaj, Edison, Eleftheriou, Konstantinos, Pagoni, Maria, Mpaltadakis, Ioannis, Dimopoulos, Athanasios‐Meletios, Kalomenidis, Ioannis, Pappas, Apostolos G.
Publicado 2021